Xiaocui Fang

6PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 23, 2026
IMAN: An Integrated Colorimetric Sensor for Direct Detection of PD-L1 on Extracellular Vesicles in Lung Cancer Diagnosis.

|Oct 22, 2026
A Dual-Action CXCR4-Targeted Peptide-Drug Conjugate Engineered to Enhance Antitumor Efficacy and Mitigate Myelosuppression in Pancreatic Cancer.

|Mar 23, 2026
Multivalent Peptide-Guided EZH2 Degradation Sensitizes Immune Checkpoint Therapy in TNBC.

Minxian Li, Haipeng Zhao, Lilusi Ma

|Jan 23, 2026
Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer.

Mengting Chen, Xiangyu Chu, Haipeng Zhao

|Aug 06, 2025
Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress via enhancing T cell responses and sensitizing cells to gemcitabine.

Xin Huang, Hang Wu, Ke Zhu

|Aug 10, 2017
Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5.

Xiaocui Fang, Hanyi Xie, Hongyang Duan

Pageof 1

Frequent Collaborators

3 joint publications

Yanlian Yang

3 joint publications

Chen Wang

2 joint publications

Tao Wen

2 joint publications

Chen Wang